Overview
John Burk is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Fort Worth, Texas. Dr. Burk is rated as an Experienced provider by MediFind in the treatment of Newborn Jaundice. His top areas of expertise are Cystic Fibrosis, Lung Metastases, Secondary Immunodeficiency (SID), Advanced Bronchoscopy, and Pacemaker Implantation. Dr. Burk is currently accepting new patients.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1201 Fairmount Ave, Fort Worth, TX 76104
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Texas Southwestern Medical Center At Dallas
James Finklea is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Dallas, Texas. Dr. Finklea is rated as a Distinguished provider by MediFind in the treatment of Newborn Jaundice. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Bronchiectasis, and Myringotomy.
University Of Texas Southwestern Medical Center At Dallas
Raksha Jain is a Pulmonary Medicine provider in Dallas, Texas. Dr. Jain is rated as a Distinguished provider by MediFind in the treatment of Newborn Jaundice. Her top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Bronchiectasis, and Lung Transplant.
Baylor Scott & White Advanced Lung Disease Specialists Dallas
Randall Rosenblatt is a Pulmonary Medicine specialist and a Transplant Surgeon in Dallas, Texas. Dr. Rosenblatt has been practicing medicine for over 52 years and is rated as an Advanced provider by MediFind in the treatment of Newborn Jaundice. His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pneumonia, Lung Metastases, and Lung Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cystic FibrosisDr. Burk isAdvanced. Learn about Cystic Fibrosis.
- Lung MetastasesDr. Burk isAdvanced. Learn about Lung Metastases.
- Experienced
- Acquired TracheomalaciaDr. Burk isExperienced. Learn about Acquired Tracheomalacia.
- ActinomycosisDr. Burk isExperienced. Learn about Actinomycosis.
- Acute Interstitial PneumoniaDr. Burk isExperienced. Learn about Acute Interstitial Pneumonia.
- Acute Respiratory Distress Syndrome (ARDS)
- Advanced BronchoscopyDr. Burk isExperienced. Learn about Advanced Bronchoscopy.
- ALK-Positive Non-Small Cell Lung Cancer